Quality of Life and Nutritional Improvements in Cirrhotic Patients

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Liver Cirrhosis, Hepatic Encephalopathy, Portal Hypertension

In brief

The purpose of this study is to determine whether taking Rifaximin (Xifaxan) in conjunction with the use of nutritional concepts is effective in improving morbidity and quality of life in cirrhotic patients suffering from hepatic encephalopathy (HE).

Key facts

Study ID
NCT01842113
Run by
Tampa General Hospital
People needed
4
Starts
2013-04-01
Last updated by the study team
2013-09-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.